Back

Prognostic value of three-dimensional regurgitant orifice determination in functional mitral regurgitation

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: It is all about heart failure Transoesophageal Echocardiography (TOE) ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Jesus Diz Diaz

National Centre for Cardiovascular Research (CNIC), Madrid (Spain)

6 More presentations in this session

Presentation thumbnail
Prognosis of diastolic dysfunction in patients with preserved LVEF. Value of left atrial strain.
Mr I. Rodriguez-Sanchez (Galdakao, ES)
Abstract Slides Video
Presentation thumbnail
Treatment with sacubitril/valsartan and improvement of ventricular-arterial coupling in heart failure with reduced ejection fraction
Doctor T. Stegmann (Leipzig, DE)
Abstract Slides Video
Presentation thumbnail
Postsystolic shortening by speckle tracking echocardiography predicts cardiovascular events and death in the general population
Mrs N. Lindhardt (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Clinical characteristics and outcomes of left ventricular thrombus patients with mildly reduced and preserved left ventricular ejection fraction
Doctor F. Goh (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Right ventricular pulmonary arterial coupling in patients with implanted left ventricular assist devices
Doctor M. Stapor (Krakow, PL)
Abstract Slides Video

Access the full session

Session thumbnail
It is all about heart failure

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
The prevalence and prognosis of severe atrial functional mitral regurgitation varies with its definition: insights from a large clinical database
thumbnail
Congress Presentation
Prognostic impact of normalizing 3D mitral RegVol to LAVmax in HFrEF patients with ventricular secondary MR
thumbnail
Congress Presentation
Prognostic significance of functional mitral regurgitation in patients with HFpEF and atrial fibrillation after optimal medical therapies

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources